YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Lamictal

Epilepsy Drugs Targeted for Black Box Suicide Warning

Jul 8, 2008 | Parker Waichman Alonso LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...

New Suicide Warning for Epilepsy Drugs

Jun 12, 2008 | Parker Waichman Alonso LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior.  The...

Epilepsy Drugs to Get Suicide Warnings, FDA Confirms

Jun 6, 2008 | Parker Waichman Alonso LLP
US regulators are very close to finalizing new suicide warnings for 11 epilepsy drugs, The Wall Street Journal reported today.  This past...

Epilepsy Drugs Double Suicide Risks, FDA Warns

Feb 2, 2008 | Parker Waichman Alonso LLP
Epilepsy drugs have been linked to a increased risk of suicidal thoughts and behavior, the Food & Drug Administration (FDA) warned this...

Glaxo bipolar drug may be tied to defect

Sep 29, 2006 | AP
Federal health officials cautioned women Friday that use of a GlaxoSmithKline drug during the first three months of pregnancy shows possible links to...

Glaxo Bipolar Drug May Be Tied to Defects

Sep 29, 2006 | AP
Federal health officials cautioned women Friday that use of a GlaxoSmithKline drug during the first three months of pregnancy shows possible links to...

First-Trimester Exposure to Lamictal May Cause Oral Cleft

Sep 29, 2006 | Medscape
The US Food and Drug Administration (FDA) has notified healthcare professionals regarding new preliminary information from the North American...

Company notes association between anti-epileptic drug, cleft palate in babies

Aug 9, 2006 | Canadian Press
Drugmaker GlaxoSmithKline is informing pregnant women of a possible association between an anti-epileptic medication and cleft palate or cleft lip in...

Page 1/1

Defective Drugs
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Name of drug:

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News